{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:18:10Z","timestamp":1791289090932,"version":"4.3.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2882,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jacc.2005.06.056","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T11:14:28Z","timestamp":1126610068000},"page":"1249-1257","source":"Crossref","is-referenced-by-count":94,"title":["Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes"],"prefix":"10.1016","volume":"46","author":[{"given":"Ziad","family":"Mallat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph. Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Benessiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar H.","family":"Dabbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn F.","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dauphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Sibella","family":"Arguelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Hugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Freyssinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Asselain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Tedgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2005.06.056_bib1","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","article-title":"Diversity of group types, regulation, and function of phospholipase A2","volume":"269","author":"Dennis","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2005.06.056_bib2","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.ATV.17.10.2257","article-title":"Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall","volume":"17","author":"Elinder","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2005.06.056_bib3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.ATV.19.5.1284","article-title":"Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2","volume":"19","author":"Ivandic","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2005.06.056_bib4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","article-title":"Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease","volume":"100","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib5","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.ehj.2003.07.003","article-title":"Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"24","author":"Liu","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2005.06.056_bib6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9149(00)01069-9","article-title":"Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris","volume":"86","author":"Kugiyama","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2005.06.056_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/mhj.2001.112404","article-title":"Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project","volume":"141","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2005.06.056_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0002-9149(02)02489-X","article-title":"Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)","volume":"90","author":"Steg","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2005.06.056_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0003-2697(89)90022-5","article-title":"A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin","volume":"177","author":"Radvanyi","year":"1989","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jacc.2005.06.056_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0006-291X(91)91035-B","article-title":"Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release","volume":"178","author":"Pernas","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2005.06.056_bib12","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2005.06.056_bib13","doi-asserted-by":"crossref","first-page":"II2","DOI":"10.1161\/01.CIR.0000129535.04194.38","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2005.06.056_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2005.06.056_bib16","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis In Myocardial Infarction","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2005.06.056_bib17","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial","volume":"35","author":"Heeschen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2005.06.056_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2005.06.056_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","article-title":"N-terminal probrain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.CIR.0000012625.02748.62","article-title":"Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients","volume":"105","author":"Mueller","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1067\/mhj.2002.125622","article-title":"C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction","volume":"144","author":"Zairis","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2005.06.056_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2796.2003.01181.x","article-title":"Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis","volume":"254","author":"Bennermo","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2005.06.056_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0002-9149(98)00490-1","article-title":"Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris","volume":"82","author":"Benamer","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2005.06.056_bib24","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2005.06.056_bib25","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Mallat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib26","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(\u2212\/\u2212) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2005.06.056_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib28","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","article-title":"Interleukin-18 and the risk of coronary heart disease in European men","volume":"108","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.RES.72.1.161","article-title":"Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta","volume":"72","author":"Mangin","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2005.06.056_bib30","first-page":"143","article-title":"Phospholipase A2\u2014a mediator between proximal and distal effectors of inflammation","volume":"12","author":"Pruzanski","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.jacc.2005.06.056_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0929-7855(95)00013-G","article-title":"Secretory phospholipases A2","volume":"12","author":"Murakami","year":"1995","journal-title":"J Lipid Mediat Cell Signal"},{"key":"10.1016\/j.jacc.2005.06.056_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0021-9150(95)05604-1","article-title":"Secretory group II phospholipase A2 in human atherosclerotic plaques","volume":"118","author":"Menschikowski","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2005.06.056_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.ATV.17.2.300","article-title":"Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins","volume":"17","author":"Hurt-Camejo","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2005.06.056_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(90)81042-M","article-title":"Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid","volume":"273","author":"Nakano","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jacc.2005.06.056_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0021-9258(18)54010-2","article-title":"Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2","volume":"268","author":"Murakami","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2005.06.056_bib36","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1074\/jbc.273.3.1733","article-title":"Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts","volume":"273","author":"Kuwata","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2005.06.056_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.ATV.19.5.1291","article-title":"Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids","volume":"19","author":"Leitinger","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2005.06.056_bib38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2005.06.056_bib39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(95)90295-3","article-title":"Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells","volume":"80","author":"Fourcade","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2005.06.056_bib40","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/PL00000678","article-title":"Lysophosphatidic acid","volume":"57","author":"Swarthout","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacc.2005.06.056_bib41","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI115932","article-title":"Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells","volume":"90","author":"Kume","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2005.06.056_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2571(97)00002-2","article-title":"Regulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesis","volume":"38","author":"Fourcade","year":"1998","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.jacc.2005.06.056_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.99.3.348","article-title":"Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity","volume":"99","author":"Mallat","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.101.8.841","article-title":"Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes","volume":"101","author":"Mallat","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2005.06.056_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0735-1097(99)00574-4","article-title":"Serum amyloid A predicts early mortality in acute coronary syndromes","volume":"35","author":"Morrow","year":"2000","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109705016505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109705016505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T10:42:30Z","timestamp":1626518550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109705016505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0735109705016505"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2005.06.056","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}